Gene · 4320
Papers3,235
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 3,235
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Dermatofibrosarcoma Protuberans of the Scalp Mimicking Trichilemmal Cyst: A Case Report. | Cureus | 2023 | 37351223 | PubTator, text mining | PubMed |
| Spatial determination and prognostic impact of the fibroblast transcriptome in pancreatic ductal adenocarcinoma. | Elife | 2023 | 37350578 | PubTator, text mining | PubMed |
| Mutagenesis and structural studies reveal the basis for the specific binding of SARS-CoV-2 SL3 RNA element with human TIA1 protein. | Nat Commun | 2023 | 37349329 | PubTator, text mining | PubMed |
| Multi-parametric sensing by multi-channel molecular fluorescent probes based on excited state intramolecular proton transfer and charge transfer processes. | BBA Adv | 2023 | 37347000 | PubTator, text mining | PubMed |
| ALOX5AP suppresses osteosarcoma progression via Wnt/β-catenin/EMT pathway and associates with clinical prognosis and immune infiltration. | J Orthop Surg Res | 2023 | 37344882 | PubTator, text mining | PubMed |
| Epigenetic regulation of hybrid epithelial-mesenchymal cell states in cancer. | Oncogene | 2023 | 37344626 | PubTator, text mining | PubMed |
| Discovery and Optimization of the First ATP Competitive Type-III c-MET Inhibitor. | J Med Chem | 2023 | 37343272 | PubTator, text mining | PubMed |
| Aberrant expression of bone morphogenetic proteins in the disease progression and metastasis of breast cancer. | Front Oncol | 2023 | 37333824 | PubTator, text mining | PubMed |
| H3K27me3-modulated Hofbauer cell BMP2 signalling enhancement compensates for shallow trophoblast invasion in preeclampsia. | EBioMedicine | 2023 | 37331163 | PubTator, text mining | PubMed |
| Stepwise Assembly of Quinary Multivariate Metal-Organic Frameworks via Diversified Linker Exchange and Installation. | J Am Chem Soc | 2023 | 37318755 | PubTator, text mining | PubMed |
| Determination of ethanol, isopropyl alcohol and methanol in alcohol-based hand sanitiser to ensure product quality, safety and efficacy. | Sci Rep | 2023 | 37301842 | PubTator, text mining | PubMed |
| Catalytic domain-dependent and -independent transcriptional activities of the tumour suppressor histone H3K27 demethylase UTX/KDM6A in specific cancer types. | Epigenetics | 2023 | 37300822 | PubTator, text mining | PubMed |
| Next-Generation Sequencing and Triple-Negative Breast Cancer: Insights and Applications. | Int J Mol Sci | 2023 | 37298642 | PubTator, text mining | PubMed |
| The potential of epigallocatechin gallate in the chemoprevention and therapy of hepatocellular carcinoma. | Front Pharmacol | 2023 | 37292151 | PubTator, text mining | PubMed |
| A Study Based on Network Pharmacology Decoding the Multi-Target Mechanism of Duhuo Jisheng Decoction for the Treatment of Intervertebral Disc Degeneration. | Comput Intell Neurosci | 2023 | 37288170 | PubTator, text mining | PubMed |
| BrcaDx: precise identification of breast cancer from expression data using a minimal set of features. | Front Bioinform | 2023 | 37287543 | PubTator, text mining | PubMed |
| The preference signature of the SARS-CoV-2 Nucleocapsid NTD for its 5'-genomic RNA elements. | Nat Commun | 2023 | 37286558 | PubTator, text mining | PubMed |
| The increased cfRNA of TNFSF4 in peripheral blood at late gestation and preterm labor: its implication as a noninvasive biomarker for premature delivery. | Front Immunol | 2023 | 37275889 | PubTator, text mining | PubMed |
| Genomic approaches to identify and investigate genes associated with atrial fibrillation and heart failure susceptibility. | Hum Genomics | 2023 | 37270590 | PubTator, text mining | PubMed |
| The expression characteristics of transmembrane protein genes in pancreatic ductal adenocarcinoma through comprehensive analysis of bulk and single-cell RNA sequence. | Front Oncol | 2023 | 37265785 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4320/papers?page=16